Yidu Tech, Inc. 2158
HKEX · Hong Kong SAR China · Technology Services
HKD 3.44+0.00 (+0.15%)
Market closed· · HKD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · HKD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
On July 2, Yidu Tech (02158.HK), a leading AI healthcare company, held its annual results presentation to review its financial performance for the fiscal year ended March 31, 2026 ("FY2026").
On June 23, at the 17th Annual Meeting of the New Champions (Summer Davos 2026) hosted by the World Economic Forum in Dalian, Gong Yingying, Founder and Chairlady of Yidu Tech, participated in the panel discussion "Faster Drugs, Better Access?". She shared her perspectives on the structural transformation of global pharmaceutical R&D and how AI and healthcare data infrastructure are reshaping drug development and clinical practice.
As global markets navigate a landscape marked by record highs in major U.S. stock indexes and robust retail sales growth, the technology sector continues to capture investor attention with its potential for innovation and expansion. In this context, identifying high-growth tech stocks with global potential involves looking at companies that not only capitalize on the current demand for AI and related technologies but also demonstrate resilience in managing economic uncertainties such as...
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.